Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protective Mechanisms of Prenatal Aspirin Therapy on Maternal Vascular Dysfunction Following Preeclampsia

NCT05653973 is registered in ClinicalTrials.gov with Anna Stanhewicz, PhD as lead sponsor.

NCT NCT05653973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05653973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protective Mechanisms of Prenatal Aspirin Therapy on Maternal Vascular Dysfunction Following Preeclampsia
Lead sponsor
Anna Stanhewicz, PhD
Phase
Phase 1
Overall status
Recruiting
Start date
January 3, 2023
Completion date
July 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microvascular function, preeclampsia